These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
4. Direct or reverse correlations within the expression of activation, differentiation or T-B cooperation molecules on chronic lymphocytic leukemia B cells. Sellitto A, De Fanis U, Romano C, Dalla Mora L, Guastafierro S, Tirelli A, Lucivero G. Minerva Med; 2003 Oct; 94(5):331-6, 336-9. PubMed ID: 14973427 [Abstract] [Full Text] [Related]
5. Effects of preactivated autologous T lymphocytes on CD80, CD86 and CD95 expression by chronic lymphocytic leukemia B cells. Romano C, De Fanis U, Sellitto A, Dalla Mora L, Chiurazzi F, Giunta R, Rotoli B, Lucivero G. Leuk Lymphoma; 2003 Nov; 44(11):1963-71. PubMed ID: 14738151 [Abstract] [Full Text] [Related]
6. Diminished DNA synthesis in T cells from B chronic lymphocytic leukemia after phytohemagglutinin, anti-CD3, and phorbol myristate acetate mitogenic signals. Prieto A, Garcia-Suarez J, Reyes E, Lapeña P, Hernandez M, Alvarez-Mon M. Exp Hematol; 1993 Nov; 21(12):1563-9. PubMed ID: 8405237 [Abstract] [Full Text] [Related]
7. Expression of CD10 by B-chronic lymphocytic leukemia cells undergoing apoptosis in vivo and in vitro. Morabito F, Mangiola M, Rapezzi D, Zupo S, Oliva BM, Ferraris AM, Spriano M, Rossi E, Stelitano C, Callea V, Cutrona G, Ferrarini M. Haematologica; 2003 Aug; 88(8):864-73. PubMed ID: 12935974 [Abstract] [Full Text] [Related]
11. Surface membrane antigen expression changes induced in vitro by exogenous growth factors in chronic lymphocytic leukemia cells. Vilpo J, Hulkkonen J, Hurme M, Vilpo L. Leukemia; 2002 Sep; 16(9):1691-8. PubMed ID: 12200683 [Abstract] [Full Text] [Related]
12. Predominantly post-transcriptional regulation of activation molecules in chronic lymphocytic leukemia: the case of transferrin receptors. Chiotoglou I, Smilevska T, Samara M, Likousi S, Belessi C, Athanasiadou I, Stavroyianni N, Samara S, Laoutaris N, Vamvakopoulos N, Anagnostopoulos A, Fassas A, Stamatopoulos K, Kollia P. Blood Cells Mol Dis; 2008 Sep; 41(2):203-9. PubMed ID: 18621559 [Abstract] [Full Text] [Related]
14. Differential expression of BCL-2 oncoprotein and Fas antigen on normal peripheral blood and leukemic bone marrow cells. A flow cytometric analysis. Molica S, Mannella A, Dattilo A, Levato D, Iuliano F, Peta A, Consarino C, Magro S. Haematologica; 1996 Sep; 81(4):302-9. PubMed ID: 8870373 [Abstract] [Full Text] [Related]
15. Abnormal intracellular level of Bax in CD3+ cells from untreated B-cell chronic lymphocytic leukemia patients. Scamardella F, Maconi M, Albertazzi L, Gamberi B, Gugliotta L, Brini M. Lab Hematol; 2006 Sep; 12(4):187-92. PubMed ID: 17118768 [Abstract] [Full Text] [Related]
17. Mitogen induced activation, proliferation and surface antigen expression patterns in unmutated and hypermutated chronic lymphocytic leukemia cells. Vilpo J, Tobin G, Hulkkonen J, Hurme M, Thunberg U, Sundström C, Vilpo L, Rosenquist R. Eur J Haematol; 2005 Jul; 75(1):34-40. PubMed ID: 15946308 [Abstract] [Full Text] [Related]
18. Withdrawal of 2-mercaptoethanol induces apoptosis in a B-cell line via Fas upregulation. Neumann D, Zierke M, Martin MU. J Cell Physiol; 1998 Oct; 177(1):68-75. PubMed ID: 9731746 [Abstract] [Full Text] [Related]